Skip to main content
Top
Published in: International Journal of Hematology 5/2014

01-11-2014 | Images in Hematology

Crossed cerebellar diaschisis due to cerebral diffuse large B cell lymphoma on 18F-FDG PET/CT

Authors: Eugene J. Teoh, Alexander L. Green, Kevin M. Bradley

Published in: International Journal of Hematology | Issue 5/2014

Login to get access

Excerpt

A 55-year-old male with a history of diffuse large B cell lymphoma (DLBCL) presented with right-arm weakness, expressive dysphasia, and left Horner’s syndrome. CT brain demonstrated multiple left supratentorial masses, and involvement including the left midbrain (Fig. 1a). Disease recurrence was diagnosed following stereotactic biopsy. 18F-FDG PET/CT of the whole body 2 weeks post-biopsy for complete staging demonstrated the masses to be markedly FDG-avid, with the most FDG-avid focus within the left midbrain (Fig. 1b, SUVmax = 19.4). No active extracranial disease was demonstrated. There was a mild generalised reduction in metabolism throughout the left cerebral grey matter compared to the right, with reduced FDG uptake throughout the contralateral cerebellar hemisphere (Fig. 1c, d, coronal images) in keeping with crossed cerebellar diaschisis (CCD).
Metadata
Title
Crossed cerebellar diaschisis due to cerebral diffuse large B cell lymphoma on 18F-FDG PET/CT
Authors
Eugene J. Teoh
Alexander L. Green
Kevin M. Bradley
Publication date
01-11-2014
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2014
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-014-1656-1

Other articles of this Issue 5/2014

International Journal of Hematology 5/2014 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine